Sermorelin & GHRP-2 Blend (10mg) – Premium Research Peptide Blend

Welcome to Liaocheng Yixin Company, your trusted source for premium sermorelin ghrp-2 blend 10mg for research. As a specialized peptide synthesis manufacturer operating from our facility in Shandong Province, China, we provide high-quality research compounds for the global scientific community.

This blend combines Sermorelin (GRF 1-29), a biologically active fragment of growth hormone-releasing hormone (GHRH), with GHRP-2, one of the most potent synthetic ghrelin receptor agonists available for research . Together, they represent a mechanistically synergistic tool for investigating growth hormone (GH) axis regulation in vitro. Our sermorelin ghrp-2 blend 10mg for research offers investigators a reliable, high-purity compound for pituitary function and endocrine signaling studies.

What is the Sermorelin & GHRP-2 Blend?

This research blend combines two complementary peptides with distinct signaling pathways, both converging on pituitary somatotrophs:

Sermorelin (GRF 1-29)

• GHRH receptor agonist (class B GPCR)

• Activates Gs/adenylyl cyclase/cAMP/PKA pathway

• Stimulates both acute GH release and GH gene transcription

• Preserves normal GH pulsatility and feedback regulation 

GHRP-2 (Pralmorelin)

• Ghrelin receptor (GHS-R1a) agonist

• The most potent synthetic GHRP, with 2-3x the GH-releasing activity of GHRP-6 per unit dose 

• Activates Gq/PLC/IP3/PKC pathway, triggering calcium mobilization and GH exocytosis

• Suppresses somatostatin release, extending the window for GHRH action 

Key Identifiers:

• Sermorelin CAS: 86168-78-7

• Sermorelin MW: ~2,093 g/mol

• GHRP-2 CAS: 158861-67-7

• GHRP-2 MW: ~873.03 g/mol

• Purity: ≥99% verified by HPLC

Mechanism of Action in Research

Dual Receptor Activation

The blend’s research value lies in its dual-pathway design targeting two distinct receptors on the same pituitary cell . Sermorelin activates GHRH receptors, engaging the cAMP/PKA signaling cascade to stimulate GH gene transcription and build intracellular GH stores. Simultaneously, GHRP-2 activates GHS-R1a receptors, generating calcium signals that trigger the exocytosis of GH-containing vesicles .

This creates a complete “prime and trigger” system—one pathway prepares the GH stockpile, the other releases it . When both pathways are activated concurrently, research demonstrates synergistic GH responses 3-10 times greater than either peptide alone .

IGF-1 Axis Activation

The amplified GH pulses stimulate hepatic IGF-1 production, which mediates the anabolic and tissue-repair effects of the blend . In human research, a combination of GHRP-2, GHRP-6, and Sermorelin (100 mcg each, three times daily) increased mean IGF-1 levels from 159.5 ng/mL to 239.0 ng/mL—an approximate 50% elevation .

Scientific Research Applications

Pituitary Function Studies

GHRP-2 stimulates GH release from pituitary cells via the same receptor mechanism as GHRP-6, despite structural differences between the peptides . Research demonstrates that GHRP-2 and GRF act additively on GH release, confirming they operate through distinct receptors .

Synergy Research

The foundational observation supporting GHRH/GHRP combination therapy comes from studies by Bowers et al. (1990), who demonstrated that simultaneous administration of GHRH and GHRP produced GH responses 3-10 times greater than either peptide alone . This synergy has been consistently replicated across multiple species and experimental paradigms.

Metabolic Research

GHRP-2 has demonstrated effects beyond GH release, including modulation of appetite and energy metabolism through central ghrelin pathways . It produces reliable GH release even in older subjects with declining GH output, making it valuable for age-related GH decline research .

Body Composition Research

Combination therapy with GHRP-2 and Sermorelin may be beneficial in research models of wasting conditions where increases in lean body mass are desirable . The preserved pulsatile pattern preferentially activates the growth-promoting STAT5b signaling pathway and avoids GH resistance that occurs with constant receptor stimulation .

Why Choose Liaocheng Yixin Company?

When sourcing sermorelin ghrp-2 blend 10mg for research, quality and reliability are paramount. Here’s why researchers trust us:

Manufacturer-Direct Quality

We are a legitimate, licensed peptide synthesis company with a physical headquarters in Shandong Province, China. Our facility maintains strict quality control standards.

Verified Purity Standards

Every batch undergoes rigorous testing using HPLC analysis. Certificates of Analysis are available upon request.

Research-Grade Specifications

• Purity: ≥99% verified by HPLC

• Appearance: White lyophilized powder

• Storage: Store powder at -20°C in a sealed container, protected from light and moisture

• Form: Lyophilized powder for research use

Quality Assurance & Testing

Every batch undergoes comprehensive quality control:

1. Synthesis by experienced chemists using solid-phase peptide synthesis

2. Purification via preparative HPLC

3. Analysis using HPLC for purity verification

4. Mass Spectrometry for molecular weight confirmation

5. Packaged in sterile conditions for research use

When you need premium sermorelin ghrp-2 blend 10mg for research for your pituitary function, endocrine signaling, or receptor synergy studies, choose a manufacturer that prioritizes quality, transparency, and reliability. Liaocheng Yixin Company combines expert peptide synthesis capabilities with rigorous quality control to deliver research materials you can trust.